Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose rifampicin chemoprophylaxis for leprosy contacts
NL-OMON27022Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- May 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in leprosy (HD) comparing Single-dose rifampicin with Placebo (2 arms). Primary endpoint: Incident leprosy cases among contacts. Started May 2002; status: active, not recruiting.
02
Drugs
rifampicin
03
Conditions
leprosy (HD)
Beyond the preview
Go deeper on NL-OMON27022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27022.